Company: EDSA
Filing Date: 2025-12-12
Form Type: 10-K
Source: 0001171843-25-007914
Chunk: 576

Company: Edesa Biotech, Inc.
Filing Date: 2025-12-12
Form: 10-K
Item: Item 2
Chunk 576
---
7894   MNP.ca

F-3

EDESA BIOTECH, INC.

Consolidated Balance Sheets

			September 30, 2025

			September 30, 2024

			Assets:

			Current assets:

			Cash and cash equivalents

			$
			10,792,172

			$
			1,037,320

			Accounts and other receivable

			642,866

			270,908

			Prepaid expenses and other current assets

			77,838

			367,394

			Total current assets

			11,512,876

			1,675,622

			Non-current assets:

			Long-term deposits

			39,966

			41,151

			Intangible asset, net

			1,977,676

			2,078,848

			Right-of-use assets

			-

			18,361

			Total assets

			$
			13,530,518

			$
			3,813,982

			Liabilities and shareholders' equity:

			Current liabilities:

			Accounts payable and accrued liabilities

			$
			1,078,536

			$
			1,812,960

			Short-term right-of-use lease liabilities

			-

			19,867

			Total current liabilities

			1,078,536

			1,832,827

			Shareholders' equity:

			Capital shares

			Authorized unlimited common shares without par value

			Issued and outstanding:

			7,141,783 common shares (September 30, 2024 - 3,247,389)

			54,515,421

			47,236,024

			Authorized preferred shares issued and outstanding

			150 Series A-1 preferred shares (September 30, 2024 - 0)

			1,092,133

			-

			834 Series B-1 preferred shares (September 30, 2024 - 0)

			8,168,063

			-

			Additional paid-in capital

			14,753,110

			13,576,757

			Accumulated other comprehensive loss

			(165,771
			)

			(